ID: h-1e2b7f1c
Hypothesis

VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking

VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking.
🧬 VPS35 (VPS26/VPS29/VPS35 complex)🩺 proteomics🎯 Composite 52%💱 $0.53▲4.5%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 5 support 6 oppose
⚠ Missing Evidence⚠ Thin Description Senate Quality Gates →
Mechanistic 0.65 (15%) Evidence 0.53 (15%) Novelty 0.55 (12%) Feasibility 0.55 (12%) Impact 0.60 (12%) Druggability 0.55 (10%) Safety 0.50 (8%) Competition 0.45 (6%) Data Avail. 0.50 (5%) Reproducible 0.55 (5%) KG Connect 0.50 (8%) 0.525 composite

🧪 Overview

VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["VPS35-VPS26-VPS29<br/>Retromer Core Trimer"]
    B["Endosomal Cargo Recognition<br/>CI-MPR/ATG9/SorLA Retrieval"]
    C["Retrograde Trafficking<br/>Endosome-to-TGN"]
    D["WASH Complex Recruitment<br/>Actin Branching on Endosome"]
    E["Cathepsin D Maturation<br/>Lysosomal Hydrolase Sorted"]
    F["VPS35 D620N Mutation<br/>Parkinson's PARK17"]
    G["Lysosomal Dysfunction<br/>Alpha-Synuclein Accumulation"]
    A --> B
    B --> C
    C --> D
    C --> E
    F -.->|"impairs"| A
    F --> G
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style E fill:#1b5e20,stroke:#81c784,color:#81c784
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports6 contradicts
Supports
VPS35 mutations cause autosomal-dominant Parkinson's disease with synaptic dysfunction
Supports
Retromer protein levels are reduced in AD hippocampus and correlate with cognitive decline
Supports
Retromer dysfunction causes APP mislocalization to endosomes, increasing Aβ production
Supports
R55 compound rescues VPS35 mutations and restores retromer function in cellular models
Supports
Retromer mediates retrieval of synaptic receptors (APP, Vps10, SorLA) from degradative pathway
Contradicts
VPS35 mutations cause Parkinson's, not Alzheimer's - mechanistic disconnect
Contradicts
VPS35 overexpression in mouse models causes dopamine neuron degeneration
Contradicts
Retromer enhancement increases Aβ production in some cellular models by redirecting APP to amyloidogenic compartments
Contradicts
R55 compound validation limited to HeLa cells and yeast; no human neuron data
Contradicts
Retromer affects thousands of cargo including Wntless, glutamate receptors, transferrin receptor
Contradicts
Correlation between VPS35 levels and cognitive decline may be secondary to neurodegeneration
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — VPS35

No curated PDB or AlphaFold mapping for VPS35 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for VPS35 (VPS26/VPS29/VPS35 complex) from GTEx v10.

Cerebellar Hemisphere34.4 Frontal Cortex BA933.4 Cerebellum26.2 Hypothalamus25.3 Cortex22.4 Spinal cord cervical c-120.6 Anterior cingulate cortex BA2420.6 Nucleus accumbens basal ganglia19.9 Caudate basal ganglia18.0 Substantia nigra16.9 Hippocampus14.7 Amygdala13.7 Putamen basal ganglia13.4median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for VPS35 (VPS26 →

No DepMap CRISPR Chronos data found for VPS35 (VPS26.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0145
Events (7d)
0
Price History
▲4.5%

💾 Resource Usage

LLM Tokens
39,448
$0.1183
Total Cost
$0.1183

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF VPS35 protein levels are restored to ≥80% of wild-type levels in VPS35-knockdown SH-SY5Y neuronal cells via CRISPR-activation, THEN the surface expression of the retromer cargo protein SorLA will iSorLA surface expression will increase by ≥2-fold, quantified by cell-surface biotinylation assay and flow cytometry.— no observation —pending0.60
IF VPS35 expression is restored via viral transduction (AAV-VPS35) in VPS35-deficient patient-derived fibroblasts, THEN the rate of transferrin receptor recycling will increase by at least 40% compareTransferrin receptor recycling rate will increase by ≥40% relative to baseline deficiency, measured by live-cell imaging of fluorescent transferrin.— no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF VPS35 expression is restored via viral transduction (AAV-VPS35) in VPS35-deficient patient-derived fibroblasts, THEN the rate of transferrin receptor recycling will increase by at least 40% compared to non-transduced VPS35-deficient cells within 72 hours post-transduction.
Predicted outcome: Transferrin receptor recycling rate will increase by ≥40% relative to baseline deficiency, measured by live-cell imaging of fluorescent transferrin.
Falsification: Transferrin receptor recycling rate remains below 20% of wild-type levels, or endosomal cargo mislocalization persists (≥80% of cells showing cytoplasmic aggregation of retromer cargo proteins CI-M6PR
pendingconf 60%
IF VPS35 protein levels are restored to ≥80% of wild-type levels in VPS35-knockdown SH-SY5Y neuronal cells via CRISPR-activation, THEN the surface expression of the retromer cargo protein SorLA will increase by at least 2-fold compared to non-activated knockdown cells within 48 hours.
Predicted outcome: SorLA surface expression will increase by ≥2-fold, quantified by cell-surface biotinylation assay and flow cytometry.
Falsification: SorLA surface expression shows no statistically significant increase (p>0.05, n=4 replicates), or total cellular SorLA levels remain ≥50% below wild-type controls indicating trafficking block persists
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.